Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Global Medical REIT (GMRE-PA) over the last 10 years, with Q3 2025 value amounting to $18.9 million.

  • Global Medical REIT's Other Non-Current Liabilities rose 5269.2% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.9 million, marking a year-over-year increase of 5269.2%. This contributed to the annual value of $14.2 million for FY2024, which is 1112.76% up from last year.
  • Latest data reveals that Global Medical REIT reported Other Non-Current Liabilities of $18.9 million as of Q3 2025, which was up 5269.2% from $18.4 million recorded in Q2 2025.
  • Global Medical REIT's Other Non-Current Liabilities' 5-year high stood at $18.9 million during Q3 2025, with a 5-year trough of $6.8 million in Q3 2022.
  • Over the past 5 years, Global Medical REIT's median Other Non-Current Liabilities value was $12.4 million (recorded in 2024), while the average stood at $12.0 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 5692.8% in 2021, then soared by 7724.88% in 2023.
  • Quarter analysis of 5 years shows Global Medical REIT's Other Non-Current Liabilities stood at $7.8 million in 2021, then decreased by 5.48% to $7.4 million in 2022, then soared by 73.43% to $12.8 million in 2023, then rose by 11.13% to $14.2 million in 2024, then soared by 33.1% to $18.9 million in 2025.
  • Its last three reported values are $18.9 million in Q3 2025, $18.4 million for Q2 2025, and $16.0 million during Q1 2025.